Minty fresh hope: l-menthol tested for lung disease breathlessness

NCT ID NCT07398287

Recruiting now Symptom relief Sponsor: Region Skane Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether L-menthol, a minty compound, can reduce breathlessness and help people with interstitial lung disease (ILD) exercise longer. About 20 adults with ILD will try L-menthol and a placebo in random order, comparing their breathing and exercise ability. The goal is to find a simple, safe way to ease a common and distressing symptom.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE (ILD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyspnea interstitial lung disease Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERSTITIAL LUNG DISEASE (ILD)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Blekinge Institute of Technology
RECRUITING

Karlskrona, Blekinge County, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••
Lund University hospital and Region Skåne
RECRUITING

Lund, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••